Enzo Biochem Inc/ US2941001024 /
| 2024-04-15 10:10:00 PM | Chg. -0.01 | Volume | Bid2:55:39 PM | Ask2:55:39 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1.16USD | -0.85% | 117,279 Turnover: 125,945 |
1.15Bid Size: 8,600 | 1.29Ask Size: 100 | 59.42 mill.USD | - | 2.83 |
Assets
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Property and Equipment | 14.2540 | 14.4820 | 16.5850 | 17.2590 | 13.0860 | ||||||
| Intangible Assets | 1.0320 | .5380 | .2440 | 0.0000 | - | ||||||
| Long-Term Investments | - | - | - | - | - | ||||||
| Fixed Assets | 25.1870 | 43.7730 | 43.1090 | 41.5030 | 23.4240 | ||||||
| Inventories | 7.8420 | 7.7840 | 12.6520 | 15.4110 | 7.9390 | ||||||
| Accounts Receivable | 10.7380 | 9.1410 | 10.1980 | 11.5160 | 4.8080 | ||||||
| Cash and Cash Equivalents | 60.1460 | 47.8650 | 13.5240 | 21.6030 | 82.3730 | ||||||
| Current Assets | 81.4530 | 68.7650 | 70.5820 | 54.3540 | 98.4560 | ||||||
| Total Assets | 106.6400 | 112.5380 | 113.6910 | 95.8570 | 121.8800 | ||||||
Liabilities
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Accounts Payable | 7.2560 | 8.5030 | 8.1230 | 8.5080 | 3.5750 | ||||||
| Long-term debt | 4.1790 | 4.4850 | 4.4710 | 4.0860 | .2690 | ||||||
| Liabilities to Banks | - | - | - | - | - | ||||||
| Provisions | 8.4000 | 12.8000 | - | - | - | ||||||
| Liabilities | 20.6120 | 54.1570 | 45.1050 | 41.3950 | 43.4180 | ||||||
| Share Capital | .4760 | .4790 | .4850 | .4870 | .4990 | ||||||
| Total Equity | 86.0280 | 58.3810 | 68.5860 | 54.4620 | 78.4620 | ||||||
| Minority Interests | - | - | - | - | - | ||||||
| Total liabilities equity | 106.6400 | 112.5380 | 113.6910 | 95.8570 | 121.8800 | ||||||
Income Statement
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | 81.1700 | 76.0210 | 117.7310 | 107.0710 | 31.0610 | ||||||
| Depreciation (total) | 3.0360 | 2.7800 | 2.6530 | - | - | ||||||
| Operating Result | 1.7330 | -30.3670 | .6920 | -15.0070 | -24.7360 | ||||||
| Interest Income | 1.0560 | .4540 | .0080 | .1590 | -1.1220 | ||||||
| Income Before Taxes | 2.4890 | -28.5200 | 7.8750 | -18.2610 | -25.0220 | ||||||
| Income Taxes | 0.0000 | 0.0000 | 0.0000 | 0.0000 | - | ||||||
| Minority Interests Profit | - | - | - | - | - | ||||||
| Net Income | 2.4890 | -28.5200 | 7.8750 | -18.2610 | 20.2880 | ||||||
Per Share
Cash Flow
|
2019 US GAAP in mill. USD |
2020 US GAAP in mill. USD |
2021 US GAAP in mill. USD |
2022 US GAAP in mill. USD |
2023 US GAAP in mill. USD |
||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash Flow from Operating Activities | 4.8060 | -17.1790 | .3870 | -16.5900 | -36.9760 | ||||||
| Cash Flow from Investing Activities | -8.1260 | -2.1700 | -34.4970 | 25.2230 | 98.9800 | ||||||
| Cash Flow from Financing | 4.1930 | 7.0010 | -.2420 | -.2410 | -1.1250 | ||||||
| Decrease / Increase in Cash | .8550 | -12.2810 | -34.3410 | 8.3290 | 60.7700 | ||||||
| Employees | 500 | 448 | - | - | - | ||||||
